Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Protein Science : a Publication of the Protein Society|June 1, 1994
Identification of glutamate 344 as the catalytic residue in the active site of pig heart CoA transferaseJ C Rochet, W A BridgerCurrent Opinion in Structural Biology|February 19, 2000
Amyloid fibrillogenesis: themes and variationsJ C Rochet, P T LansburyBiochemistry|September 9, 2000
Inhibition of fibrillization and accumulation of prefibrillar oligomers in mixtures of human and mouse alpha-synucleinJ C Rochet, K A Conway, P T LansburyScience (New York, N.Y.)|November 10, 2001
Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adductK A Conway, J C Rochet, R M Bieganski, et al.Journal of Nanoscience and Nanotechnology|May 10, 2008
Biotemplated synthesis of metallic nanoparticle chains on an alpha-synuclein fiber scaffoldR Colby, J Hulleman, S Padalkar, et al.Journal of Nanoparticle Research : an Interdisciplinary Forum for Nanoscale Science and Technology|August 2, 2011
Fabrication of ZnS nanoparticle chains on a protein templateS Padalkar, J Hulleman, S M Kim, et al.Nanotechnology|August 11, 2011
Protein-templated semiconductor nanoparticle chainsS Padalkar, J D Hulleman, S M Kim, et al.Biochemistry|July 22, 1997
Productive interactions between the two domains of pig heart CoA transferase during folding and assemblyJ C Rochet, K Oikawa, L D Hicks, et al.Proceedings of the National Academy of Sciences of the United States of America|January 19, 2000
Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapyK A Conway, S J Lee, J C Rochet, et al.Biochemistry|June 27, 2001
Vesicle permeabilization by protofibrillar alpha-synuclein: implications for the pathogenesis and treatment of Parkinson's diseaseM J Volles, S J Lee, J C Rochet, et al.Pageof 2